127 filings
8-K
PBLA
Panbela Therapeutics, Inc.
25 Apr 24
Entry into a Material Definitive Agreement
4:35pm
8-K
PBLA
Panbela Therapeutics, Inc.
22 Apr 24
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
8:02am
8-K
PBLA
Panbela Therapeutics, Inc.
17 Apr 24
Panbela Announces Transfer to OTCQB Market
8:36am
8-K
PBLA
Panbela Therapeutics, Inc.
26 Mar 24
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
4:12pm
8-K
PBLA
Panbela Therapeutics, Inc.
7 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:01am
8-K
5m8g5izbzv499 kq0
15 Feb 24
Regulation FD Disclosure
8:05am
8-K
joapzdcl8
13 Feb 24
Departure of Directors or Certain Officers
5:24pm
8-K
ro8mwm6ax3l wfim
1 Feb 24
Panbela Announces Closing of Approximately $9.0 Million Public Offering
7:15am
8-K
ze05c gfgan9
29 Jan 24
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
6:21am
8-K
y0q0k2tn4rnt qkx9
25 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
0pk2899g9z0l0ds2v
19 Jan 24
Material Modifications to Rights of Security Holders
5:20pm
8-K
n6at8t1z3nbwsul3
21 Dec 23
Entry into a Material Definitive Agreement
9:25am
8-K
8bmbuuo646x6evgrtq
21 Dec 23
Submission of Matters to a Vote of Security Holders
6:00am
8-K
1l04azq1
1 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
nwkbbv9c
9 Nov 23
Panbela Provides Business Update and Reports Q3 2023 Financial Results
4:10pm
8-K
pup63gtbg4ina1n
3 Nov 23
Entry into a Material Definitive Agreement
5:24pm
8-K
a03o452bkykmv5
10 Aug 23
Panbela Provides Business Update and Reports Q2 2023 Financial Results
4:11pm
8-K
ts8266iv
19 Jul 23
Regulation FD Disclosure
8:02am
8-K
cocfh0mnl41w
10 Jul 23
Regulation FD Disclosure
4:15pm
8-K
yu3pd jrq
21 Jun 23
Panbela Announces Pricing of Approximately $8.5 Million Public Offering
5:00pm